Nitrous Oxide: Role in Anesthesiology and Pharmacokinetics
This agent has relatively weak anesthetic potency. For this reason, in modern clinical practice, it is almost never used as monotherapy. Most often, it is included in balanced anesthesia regimens, combined with more potent general anesthetics to ensure an adequate depth of drug-induced sleep.
Regarding pharmacokinetics, the drug behaves very simply within the body:
- It does not undergo metabolic transformations (biotransformation in the liver or other organs) at all.
- Elimination occurs almost entirely through the respiratory system. The gas leaves the body via the lungs in its original, unchanged form.
Safety Profile and Side Effects of Nitrous Oxide
The safety of use largely depends on the duration of inhalation. With short-term use, the agent demonstrates an excellent safety profile—adverse reactions are practically absent in such situations.
However, prolonged inhalations pose a serious threat to the patient's health. There is a high risk of developing severe complications affecting the hematopoietic and nervous systems:
- Leukopenia (decreased white blood cell count).
- Megaloblastic anemia.
- Neuropathy.
The mechanism of toxicity lies in the direct chemical action on vitamin B12. The agent causes oxidation of the cobalt atom, which is the central element in the structure of the cyanocobalamin molecule. As a result, marked functional vitamin B12 deficiency develops.
In addition, drug interactions must be considered. When co-administered with other anesthetic adjuncts, such as opioid analgesics or neuroleptics, hemodynamic depression may develop. Clinically, this manifests as a notable decrease in blood pressure and a drop in cardiac output.
Xenon: Properties of an Inert Gas
Unlike nitrous oxide, xenon is a noble (inert) gas. One of its key physicochemical characteristics is an extremely low blood/gas partition coefficient. In practice, this means that the agent very rapidly saturates the blood and tissues, ensuring a swift induction of anesthesia.
From a pharmacodynamics standpoint, this gas possesses several unique advantages:
- Potent analgesia: the agent provides a high degree of pain relief.
- Absence of toxicity: it does not damage cellular structures or enzyme systems.
- Cardiostability: the gas has absolutely no effect on myocardial contractility, preserving stable heart function.
- Neuroprotective effect: it protects neurons from damaging factors during surgical intervention.
Mechanisms of Action and Disadvantages of Xenon
The effects of the agent are mediated through complex interactions with the receptor apparatus of the central nervous system. The main mechanism involves the non-competitive blockade of NMDA receptors. Additionally, the gas exerts a modulatory effect on GABA-A receptors and affects a number of other glutamate receptors (beyond NMDA), which together ensure the rapid onset of the surgical stage of anesthesia and powerful analgesia.
Despite a profile close to an ideal anesthetic, its widespread use is limited by two significant disadvantages:
- Extremely high cost of the agent itself.
- The need to equip operating rooms with specialized and expensive anesthesia machines capable of operating with this gas in a closed circuit.